SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

U.S. Stem Cell Inc. (USRM)

USRM RSS Feed
Add USRM Price Alert      Hide Sticky   Hide Intro
Moderator: Poor Man -, buythebuy
Search This Board:
Last Post: 9/28/2016 9:14:19 PM - Followers: 185 - Board type: Free - Posts Today: 0




A COMMITMENT TO EXCELLENCE

Bioheart, Inc. is committed to the discovery and development of autologous cellular therapies to treat a variety of degenerative diseases, as well as the continuation of our ongoing research for the treatment of heart failure, cardiovascular and perioheral vascular disease. 

 


The Bioheart Vision
Our vision is to improve the quality of patients’ lives, while reducing hospitalizations and healthcare costs. 
Bioheart is and will continue to be recognized by physicians and patients as the world’s leader in providing 
innovative treatment and management of patients with severe cardiovascular and peripheral vascular 
disease.We are also focused on the discovery, development and commercialization of autologous cell therapies 
for the treatment of degenerative diseases.

 

.

Management:

Mike Tomás

President & CEO

Mike Tomas. Mr. Mike Tomas was appointed President and Chief Executive Officer and a member of our Board of Directors on June 19, 2010. Mike Tomas was appointed as the Company’s President and Chief Executive Officer, and as a director on June 19, 2010. Mr. Tomas has been President for the past nine years of The ASTRI Group, an early stage private equity investment company in Florida with an investment in Bioheart since 2001. In 2003, he joined Bioheart’s Board of Directors as the independent representative of The ASTRI Group. ASTRI provides capital, business development and strategic marketing support to emerging private companies. Mr. Tomas will continue to serve as President of The ASTRI Group. Previously from 1983 to 2001, Mr. Tomas held ascending executive positions including Chief Marketing Officer at Avantel, a $1 billion dollar joint venture with MCI. Upon retiring from MCI and WorldCom, Tomas joined other ex-MCI executives and helped raise $40M in venture capital to form Ineto, an integrated customer communications software solution that was successfully sold in 2001.
 
Mr. Tomas sits on the boards of Avisena (revenue cycle management company for medical practices), SilverSky (fka Perimeter Internetworking) (SaaS/managed security services provider for medical practices and financial institutions), Rokk3r Labs (a digital and mobile products developer and portfolio), Bioheart (adult stem cell development for heart muscle tissue repair) and is the current chairman of Florida International University’s Global Entrepreneurship Center. He is an inductee into the Miami-Dade College and WACE Halls of Fame for business, an FIU Torch Award winner — and winner of top communications, medical innovations, education and entrepreneurial awards. Mr. Tomas holds a Masters of Business Administration from the University of Miami and a Bachelor’s degree from Florida International University.
 

Kristin Comella

Chief Scientific Officer

Kristin Comella. Ms. Comella was appointed Chief Scientific Officer in September 2010. Ms. Comella has served as our Vice President of R&D and Corporate Development since December 2008 and has played a major role in managing our product development, manufacturing and quality systems since joining Bioheart in 2004. Ms. Comella has 15 years of industry experience with expertise in regenerative medicine, training and education, research and product development, and currently serves on multiple advisory boards in the stem cell arena. Ms. Comella has many years of cell culturing experience including building and managing the stem cell laboratory at Tulane University's Center for Gene Therapy and developing stem cell therapies for osteoarthritis at Osiris Therapeutics. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.  On March 12, 2013, Kristin Comella was appointed to serve as a member of our Board of Directors.
 

Dr. William P. Murphy, Jr.

William P. Murphy, Jr., M.D. Dr. Murphy has served as a member of our Board of Directors since June 2003. Dr. Murphy founded Small Parts, Inc., a supplier of high quality mechanical components for design engineers, in 1964 and served as its Chairman until his retirement in April 2005. Small Parts, Inc. was acquired by Amazon.com, Inc. in March 2005. From October 1999 until October 2004, Dr. Murphy served as the Chairman and Chief Executive Officer of Hyperion, Inc., a medical diagnosis company which had an involuntary bankruptcy filed against it in December 2003. Dr. Murphy is the founder of Cordis Corporation (now Cordis Johnson & Johnson) which he led as President, Chairman and Chief Executive Officer at various times during his 28 years at Cordis until his retirement in October 1985. Cordis Johnson & Johnson is a leading firm in cardiovascular instrumentation. Dr. Murphy received an M.D. in 1947 from the University of Illinois and a B.S in pre-medicine from Harvard College in 1946. He also studied physiologic instrumentation at Massachusetts Institute of Technology, or MIT. After a two year rotating internship at St. Francis Hospital in Honolulu, he became a Research Fellow in Medicine at the Peter Bent Brigham Hospital in Boston where he was the dialysis engineer on the first clinical dialysis team in the United States. He continued as an Instructor in Medicine and then a research associate in Medicine at Harvard Medical School. Dr. Murphy is the author of numerous papers and owns 17 patents. He is the recipient of a number of honors, including the prestigious Lemelson-MIT Lifetime Achievement Award, the MIT Corporate Leadership Award, the Distinguished Service Award from North American Society of Pacing and Electrophysiology, and the Jay Malina Award from the Beacon Council of Miami, Florida. He is also a member of the Inventors Hall of Fame
 

 

Executive Officers and Directors

Set forth below is information regarding our executive officers and directors as of December 31, 2013

Mike Tomas 48 Director, President and Chief Executive Officer, Chief Financial Officer
William P. Murphy, Jr., M.D. 90 Director, Chairman of the Board
Mark P. Borman  59  Director
Charles A. Hart  53 Director
Sam Ahn  59 Director
Kristen Comella  37 Director, Chief Scientific Officer
Sheldon T. Anderson 63 Director
     

Business Strategy

 Our principal objective is to become a leading regenerative medicine company that discovers, develops and commercializes novel, autologous cell therapies, and related devices, for the treatment and improved care of patients suffering from chronic and acute heart damage as well as lower limb ischemia. Our secondary objective is the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases.  The number of heart failure patients is expected to increase from 25 million worldwide today to over 50 million in five years. Our focus is on serving these patients. To achieve our primary objective, we plan to pursue the following strategies:

  • - Obtain initial regulatory approval of MyoCell and/or MyoCell SDF-1 by targeting patients with severe heart damage. 
    - Continue existing studies with adipose derived stem cells and endothelial progenitor cells.
    - Continue to develop our pipeline of cell-based therapies and related devices for the treatment of chronic and acute heart damage. 
    - Develop our sales and marketing capabilities. 
    - Continue to refine our MyoCell and MyoCell SDF-1 cell culturing processes.
    - Expand and enhance our intellectual property rights.
    - License, acquire and/or develop complementary products and technologies. 
    
BHRT - Daily Candlesticks






 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
USRM
Current Price
Volume:
Bid Ask Day's Range
SureTrader
USRM News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 04:08:00 PM
USRM News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 04:05:49 PM
USRM News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 04:04:54 PM
USRM News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 04:03:09 PM
USRM News: Statement of Changes in Beneficial Ownership (4) 09/23/2016 04:01:52 PM
PostSubject
#17650  Sticky Note SEC Microcap FRAUD UNIT "Warning" Signs Hornet Driver 09/26/16 07:53:11 PM
#17615  Sticky Note USRM DISMISSED IN ONE SUIT! buythebuy 09/24/16 08:21:11 PM
#17704   Closed at HOD. Garyst 09/28/16 09:14:19 PM
#17703   And the bid raised up too. Go USRM! buythebuy 09/28/16 03:13:04 PM
#17702   Up at the HOD now. Garyst 09/28/16 03:11:50 PM
#17701   USRM bid support growing. buythebuy 09/28/16 02:46:59 PM
#17700   Holding up so far. Garyst 09/28/16 01:45:03 PM
#17699   Agreed GO USRM! buythebuy 09/28/16 12:50:53 PM
#17698   Yeah, nothing large today but also no large Garyst 09/28/16 12:18:02 PM
#17697   Looks like there has been some buying in buythebuy 09/28/16 11:51:06 AM
#17696   Agree. USRM recently 02 to 004 yesterday. Pretty Garyst 09/28/16 11:22:28 AM
#17694   Stock Scam... InvestorStemCell 09/28/16 11:21:44 AM
#17693   It was 19 on the breakout board this buythebuy 09/28/16 11:07:50 AM
#17692   Quote LOL, "Chart looks like it could squeeze." Hornet Driver 09/28/16 10:10:32 AM
#17691   .007 PRE-MARKET TRADE, 275K shares?? Hornet Driver 09/28/16 09:58:19 AM
#17690   Chart looks like it could squeeze. Go USRM! buythebuy 09/28/16 09:41:00 AM
#17689   99.3% LOSSES..LESS THAN 10 MONTHS !! Poor Man - 09/28/16 08:17:29 AM
#17688   bounce come today, tmr and so continue http://stockcharts.com/h-sc/ui?s=USRM knrorrel 09/28/16 04:09:25 AM
#17687   I totally agree with you. It grows and kuhnstefanie 09/28/16 04:02:00 AM
#17686   That sounds good. that could really help to kuhnstefanie 09/28/16 03:54:12 AM
#17685   now #27 BB going high today and more knrorrel 09/28/16 02:18:46 AM
#17684   MEGA OVERSOLD/RSI 32! http://stockcharts.com/h-sc/ui?s=USRM knrorrel 09/28/16 12:18:19 AM
#17683   maybe soon good news? (here wanted maybe someone knrorrel 09/28/16 12:17:52 AM
#17682   here wanted someone cheap purely ( favorable shares knrorrel 09/28/16 12:15:17 AM
#17681   YEPP, BUY AND TODAY WE GOING BACK TO 0,01-0,015 knrorrel 09/28/16 12:11:39 AM
#17680   99.3% LOSSES..LESS THAN 10 MONTHS !! Hornet Driver 09/27/16 09:45:50 PM
#17679   True and that will take us down for Garyst 09/27/16 08:51:50 PM
#17678   Actually, I do have a mortgage and work Garyst 09/27/16 08:40:09 PM
#17677   Watch Video: Fight to make cutting-edge treatments accessible, affordable H20-Life 09/27/16 08:16:06 PM
#17676   From Blindness To Sight: One Man's Story Holds H20-Life 09/27/16 08:15:39 PM
#17675   Btw, Senate HELP Committee Cellular Therapy Amendment On H20-Life 09/27/16 08:15:03 PM
#17674   Short Squeeze in the mix... H20-Life 09/27/16 08:14:21 PM
#17673   Nice dip, bounce, volume, and buy opportunity... H20-Life 09/27/16 08:13:48 PM
#17672   Yeah over 1 million shares dump at one buythebuy 09/27/16 05:36:04 PM
#17671   The only reason I watch this board is toddski 09/27/16 05:05:00 PM
#17670   Good sized volume that brought it down though Garyst 09/27/16 04:03:19 PM
#17669   Could be deliberate so people can load shares. buythebuy 09/27/16 03:56:42 PM
#17668   No kidding. Would not have seen this drop coming. Garyst 09/27/16 03:55:43 PM
#17667   Definitely been an interesting day for USRM. buythebuy 09/27/16 03:48:24 PM
#17666   Looking to break back above 01 here. Garyst 09/27/16 03:35:25 PM
#17665   Power hour just around the corner. Go USRM! buythebuy 09/27/16 02:52:05 PM
#17664   Selling certainly has subsided. Garyst 09/27/16 02:51:23 PM
#17663   Seems confidence in USRM is growing at these levels. buythebuy 09/27/16 02:43:38 PM
#17662   Yeah, one for 480k and one for 610k. Garyst 09/27/16 02:31:56 PM
#17661   I think I saw one for 600k. Go USRM! buythebuy 09/27/16 02:15:16 PM
#17660   Yes, decent sized buys today. Garyst 09/27/16 01:53:51 PM
#17659   Pretty big ask slaps on the times and buythebuy 09/27/16 01:36:06 PM
#17658   Yes, no hesitation buying at those 0004/5 levels. Garyst 09/27/16 01:33:02 PM
#17657   Yes the buyers did step in 10 million buythebuy 09/27/16 01:29:47 PM
#17656   Quote LOL, "150% off LOD. Buyers certainly stepped in!" Hornet Driver 09/27/16 11:58:56 AM
#17655   150% off LOD. Buyers certainly stepped in! Garyst 09/27/16 11:45:38 AM
#17654   .004 DAY'S LOW...HOLY SH*T BATMAN ?? Hornet Driver 09/27/16 11:12:22 AM
PostSubject